AAPS Pharm Sci360
ARx Demonstrates Ability To Eliminate Toxic Metabolites With Thin Film Technology
July 23, 2018
Trends in Global Drug Delivery
July 1, 2019

AAPS Pharm Sci360

ARx is excited to present its poster, “Comparative Permeation Study of A Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet & Buccal Film” at AAPS Pharm Sci360 on Wednesday, Nov 7th at 9:30-10:30am. The poster demonstrates the rapid onset and bioavailability benefits of an optimized thin film product. Visit us at Booth 1711 to learn more.

image001